logo
Plus   Neg
Share
Email

Dr. Reddy's Labs Launches Trientine Hydrochloride Capsules In U.S.

Dr. Reddy's Laboratories Ltd. (RDY) announced Friday the launch of Trientine Hydrochloride Capsules USP, 250 mg in the US.

The drug is a therapeutically equivalent generic version of Syprine (trientine hydrochloride) Capsules, approved by the U.S. Food and Drug Administration. Trientine Hydrochloride Capsules are available in 100 count bottles.

According to IMS Health, the Syprine brand, by Alton Pharma, and generic products had U.S. sales of approximately $94.2 million for the twelve months ended December 2019.

Marc Kikuchi, Chief Executive Officer and Head of Dr. Reddy's North America Generics, said, "Our product can be stored at room temperature (20C to 25C or 68F to 77F) throughout the product shelf life of 24 months."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Tesla Inc. is planning to cut pays and furlough non-essential workers as the shut down of its vehicle production continues amid escalating coronavirus or Covid-19 cases. As per multiple reports citing an e-mail sent to all employees by North American HR Valerie Capers, the luxury electric car maker is taking certain actions starting April 13, aiming to manage costs. Facebook said it is launching new tools that will help health researchers to track and combat the spread of COVID-19 by using anonymized location data from users. The social media giant said its 'Data for Good' program is developing Disease Prevention Maps that provide details on how population movements around regions are influencing the spread of the disease. Amazon.com decided to donate 8200 laptops, worth more than $2 million, to elementary students in Seattle Public Schools (SPS) to help towards the continuous learning plan during the coronavirus (COVID-19) pandemic. SPS is the largest K-12 school system in Washington State to ensure that each student graduates ready for college, career and life.
Follow RTT
>